Predict your next investment

Venture Capital
vertexventureshc.com

See what CB Insights has to offer

Investments

28

Portfolio Exits

6

About Vertex Ventures HC

Vertex Ventures HC invests in various sectors of the healthcare industry, including biopharmaceuticals, medical devices, diagnostics, and digital health. The firm's portfolio includes companies at all stages of development, from early-stage companies testing transformative technologies to commercial-stage companies seeking additional growth.

Vertex Ventures HC Headquarter Location

345 S. California Avenue

Palo Alto, California, 94306,

United States

650-729-8810

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Vertex Ventures HC News

Allay Therapeutics Completes $60M Series C

Sep 16, 2021

Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, announced the completion of its oversubscribed $60M Series C financing, led by Arboretum Ventures. Participating in the round were NEA, Temasek, Pavilion Capital, Brandon Capital Partners, Vertex Growth, Vertex Ventures HC, and WTT Investment Ltd. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

Vertex Ventures HC Investments

28 Investments

Vertex Ventures HC has made 28 investments. Their latest investment was in Allay Therapeutics as part of their Series C on September 9, 2021.

CBI Logo

Vertex Ventures HC Investments Activity

investments chart

Vertex Ventures HC Portfolio Exits

6 Portfolio Exits

Vertex Ventures HC has 6 portfolio exits. Their latest portfolio exit was Ivantis on November 08, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/8/2021

Acquired

$991

5

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

11/8/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Exit

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

10

10

10

10

Vertex Ventures HC Team

4 Team Members

Vertex Ventures HC has 4 team members, including current Managing Director, Lincoln Chee.

Name

Work History

Title

Status

Lincoln Chee

Managing Director

Current

Lori Hu

Managing Director

Current

Carolyn Ng

Managing Director

Current

Christopher Shen

Managing Director

Current

Name

Lincoln Chee

Lori Hu

Carolyn Ng

Christopher Shen

Work History

Title

Managing Director

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.